Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
HCA Healthcare, Inc. (HCA) Q4 2025 Earnings Call Transcript
HCA's Q4 EPS surge 28.8% year over year to $8.01, beating estimates on strong patient volumes and higher revenue per equivalent admission.
The headline numbers for HCA (HCA) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
HCA Healthcare (HCA) came out with quarterly earnings of $8.01 per share, beating the Zacks Consensus Estimate of $7.36 per share. This compares to earnings of $6.22 per share a year ago.
HCA Healthcare on Tuesday forecast its profit for 2026 above Wall Street estimates as it expects lower costs and robust demand for its medical care services.
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for HCA (HCA), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025.
HCA Healthcare heads into Q4 earnings with solid admission and revenue growth, but rising costs and declining outpatient surgery cases cloud the odds of a beat.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.